Latest Breaking News On - Late breaking science - Page 1 : vimarsana.com

Data from the PRECISION study of aprocitentan to be presented at the European Society of Hypertension Annual Meeting 2024

Data from the PRECISION study of aprocitentan to be presented at the European Society of Hypertension Annual Meeting 2024
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Switzerland generalUnited statesKrzysztof narkiewiczMarkus schlaichAndrewc weissConvention hallCommittee for medicinal products human useIdorsia pharmaceuticals ltdEuropean society of cardiologySwiss exchangeUniversity of gdanskEuropean society of hypertensionIdorsia ltdHead of the department hypertensionAmerican heart associationHead of investor relations corporate communications

Idorsia Pharmaceuticals Ltd: Data from the PRECISION study of aprocitentan to be presented at the European Society of Hypertension Annual Meeting 2024

Allschwil, Switzerland - May 31, 2024 Idorsia Ltd (SIX: IDIA) today announced that data from the Phase 3 study of aprocitentan, Idorsia's endothelin receptor antagonist, will be presented by Prof.

United statesSwitzerland generalMarkus schlaichAndrewc weissKrzysztof narkiewiczUniversity of gdanskIdorsia pharmaceuticals ltdIdorsia ltdHead of investor relations corporate communicationsAmerican heart associationEuropean society of hypertensionHead of the department hypertensionSwiss exchangeEuropean society of cardiologyEuropean commissionCommittee for medicinal products human use

GNW-Adhoc: Data from the PRECISION study of aprocitentan to be presented at the European Society of Hypertension Annual Meeting 2024

GNW-Adhoc: Data from the PRECISION study of aprocitentan to be presented at the European Society of Hypertension Annual Meeting 2024
onvista.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from onvista.de Daily Mail and Mail on Sunday newspapers.

Switzerland generalUnited statesAndrewc weissKrzysztof narkiewiczMarkus schlaichIdorsia ltdConvention hallAmerican heart associationEuropean society of hypertensionSwiss exchangeEuropean commissionCommittee for medicinal productsHead of the department hypertensionUniversity of gdanskEuropean society of cardiologyEuropean society

Cryocure-VT Trial Outcomes Presented in EHRA 2024 Late-Breaking Science Session

A new technology using ultralow temperature cryoablation (ULTC) has eliminated clinical ventricular tachycardia (VT) in 94% of patients. The late-breaking science was presented this week during EHRA 2024, a scientific congress of the European Society of Cardiology (ESC).1 which took place April 7-9 in Berlin, Germany.

United statesCzech republicTrialatul vermaEuropean heart rhythm associationEuropean society of cardiologyMcgill university health centreEuropean societyAtul vermaLaguna hillsAdagio medicalLow temperature cryoablation systemLate breaking scienceEur heart

Preventive ablation of ventricular tachycardia avoids shocks and hospitalization, finds clinical trial

Preventive ablation of ventricular tachycardia avoids shocks and hospitalization, finds clinical trial
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

Slovenia generalDavid zizekEuropean society of cardiologyUniversity medical centreEuropean societyLate breaking science